Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy: first report from iran

Nephro-urology Monthly
Mohammadreza Ardalan, Parisa Rezaeifar

Abstract

Thrombotic microangiopathy (TMA) is a rare but devastating small vessels disorder that is characterized by intravascular platelet thrombi, thrombocytopenia, and various degrees of organ ischemia and anemia, which is due to erythrocyte fragmentation in microcirculation. The Aim of this study was to determine the von Willebrand factor-cleaving protease (ADAMTS13) activity during the acute phase of TMA. We also investigated inhibiting antibodies against ADAMTS13 in these patients. In a collaborative work with Mario-Negro institute of pharmacological research in Bergamo-Italy, we registered the clinical and laboratory data, collected the serum samples, and transferred the samples to the laboratories. Serum samples were taken before the start of plasmapheresis or at least 15 days after the final exchange. We recruited 40 patients (14 males and 26 females) with the mean age of 46.12 ± 17.26 years. The mean activity of ADAMTS13 was 34.58% ± 21.83%. Two patients had inhibitory antibodies against ADAMTS13 with profound deficiency of ADAMTS13 activity (< 6%). Infectious diseases were the most common underlying condition, followed by systemic lupus erythematous. Majority of patients had an underlying condition and had various ADAMTS13 act...Continue Reading

References

Nov 26, 1998·The New England Journal of Medicine·H M Tsai, E C Lian
Jul 20, 2002·Blood·Giuseppe RemuzziUNKNOWN Italian Registry of Recurrent and Familial HUS/TTP. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome
Aug 23, 2002·The New England Journal of Medicine·Joel L Moake
Feb 18, 2003·British Journal of Haematology·Sarah L AllfordUNKNOWN Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·B LämmleL Alberio
May 5, 2006·The New England Journal of Medicine·James N George
Jun 1, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mohammed Reza ArdalanMohammadali Mohajel Shoja
Feb 8, 2007·Journal of Clinical Apheresis·Christine M CsertiLynne Uhl
Aug 2, 2007·Hematology/oncology Clinics of North America·Han-Mou Tsai
Nov 21, 2007·Hematology·Pier Mannuccio Mannucci, Flora Peyvandi
Mar 12, 2008·Hypertension·Bert-Jan H van den BornGert A van Montfrans
Jun 5, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M R ArdalanH Keyvani
Apr 14, 2011·Yonsei Medical Journal·Hyoung Soo ChoiHye Won Park
Apr 11, 2013·Nephro-urology Monthly·Mohammadreza Ardalan
Jan 15, 2014·Nature Reviews. Nephrology·Marina Noris, Giuseppe Remuzzi
Apr 11, 2014·Nephro-urology Monthly·Mohammadreza Ardalan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Babesiosis

Babesiosis is caused by parasites of the genus babesia, which are transmitted in nature by the bite of an infected tick. Discover the latest research on babesiosis here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.